Viking Therapeutics Inc (VKTX)
51.66
+0.13
(+0.25%)
USD |
NASDAQ |
Nov 21, 16:00
51.96
+0.30
(+0.58%)
After-Hours: 19:54
Viking Therapeutics Market Cap: 5.757B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.742B |
| November 19, 2024 | 5.740B |
| November 18, 2024 | 5.473B |
| November 15, 2024 | 5.525B |
| November 14, 2024 | 5.970B |
| November 13, 2024 | 6.136B |
| November 12, 2024 | 6.753B |
| November 11, 2024 | 7.017B |
| November 08, 2024 | 7.631B |
| November 07, 2024 | 7.672B |
| November 06, 2024 | 7.340B |
| November 05, 2024 | 7.202B |
| November 04, 2024 | 7.036B |
| November 01, 2024 | 8.121B |
| October 31, 2024 | 8.084B |
| October 30, 2024 | 7.996B |
| October 29, 2024 | 8.174B |
| October 28, 2024 | 8.304B |
| October 25, 2024 | 8.695B |
| October 24, 2024 | 8.159B |
| October 23, 2024 | 6.730B |
| October 22, 2024 | 6.912B |
| October 21, 2024 | 7.170B |
| October 18, 2024 | 7.333B |
| October 17, 2024 | 7.200B |
| Date | Value |
|---|---|
| October 16, 2024 | 7.338B |
| October 15, 2024 | 7.286B |
| October 14, 2024 | 7.332B |
| October 11, 2024 | 7.337B |
| October 10, 2024 | 6.959B |
| October 09, 2024 | 6.980B |
| October 08, 2024 | 7.430B |
| October 07, 2024 | 7.022B |
| October 04, 2024 | 7.239B |
| October 03, 2024 | 7.144B |
| October 02, 2024 | 7.209B |
| October 01, 2024 | 6.909B |
| September 30, 2024 | 7.055B |
| September 27, 2024 | 6.828B |
| September 26, 2024 | 6.905B |
| September 25, 2024 | 6.995B |
| September 24, 2024 | 6.862B |
| September 23, 2024 | 7.203B |
| September 20, 2024 | 7.808B |
| September 19, 2024 | 7.552B |
| September 18, 2024 | 7.141B |
| September 17, 2024 | 6.974B |
| September 16, 2024 | 7.434B |
| September 13, 2024 | 7.393B |
| September 12, 2024 | 6.959B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
163.26M
Minimum
Jun 16 2022
9.989B
Maximum
Mar 04 2024
1.669B
Average
507.17M
Median
Market Cap Benchmarks
| Amgen Inc | 155.82B |
| Eli Lilly and Co | 711.90B |
| Pfizer Inc | 142.44B |
| Structure Therapeutics Inc | 1.724B |
| Altimmune Inc | 597.45M |
Market Cap Related Metrics
| Price to Book Value | 6.316 |
| Price | 51.66 |
| Earnings Yield | -1.80% |